Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Semeraro

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Haematologica|October 20, 2018
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding studyMaria Domenica Cappellini, John Porter, Raffaella Origa, et al.
Kidney International|June 19, 2026
A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney diseaseDominique Joly, Moreno Ursino, Frank Bienaimé, et al.
Cell Death Discovery|December 10, 2020
Autophagy-mediated metabolic effects of aspirinFrancesca Castoldi, Juliette Humeau, Isabelle Martins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 29, 2020
Seletalisib for Activated PI3Kδ Syndromes: Open-Label Phase 1b and Extension StudiesNieves Diaz, Maria Juarez, Caterina Cancrini, et al.
Clinical Pharmacokinetics|February 4, 2024
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Saïk Urien, Frantz Foissac, et al.
Science Translational Medicine|April 17, 2015
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patientsMichaela Semeraro, Sylvie Rusakiewicz, Véronique Minard-Colin, et al.
The New England Journal of Medicine|March 2, 2017
Gene Therapy in a Patient with Sickle Cell DiseaseJean-Antoine Ribeil, Salima Hacein-Bey-Abina, Emmanuel Payen, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Environmental Microbiology|September 6, 2022
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age childrenAgnes Delaunay-Moisan, Tiffany Guilleminot, Michaela Semeraro, et al.
Science Translational Medicine|July 26, 2013
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndromeSylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Haematologica|October 20, 2018
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding studyMaria Domenica Cappellini, John Porter, Raffaella Origa, et al.
Kidney International|June 19, 2026
A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney diseaseDominique Joly, Moreno Ursino, Frank Bienaimé, et al.
Cell Death Discovery|December 10, 2020
Autophagy-mediated metabolic effects of aspirinFrancesca Castoldi, Juliette Humeau, Isabelle Martins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 29, 2020
Seletalisib for Activated PI3Kδ Syndromes: Open-Label Phase 1b and Extension StudiesNieves Diaz, Maria Juarez, Caterina Cancrini, et al.
Clinical Pharmacokinetics|February 4, 2024
Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis: A First Step Toward Personalized TherapyNaïm Bouazza, Saïk Urien, Frantz Foissac, et al.
Science Translational Medicine|April 17, 2015
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patientsMichaela Semeraro, Sylvie Rusakiewicz, Véronique Minard-Colin, et al.
The New England Journal of Medicine|March 2, 2017
Gene Therapy in a Patient with Sickle Cell DiseaseJean-Antoine Ribeil, Salima Hacein-Bey-Abina, Emmanuel Payen, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Environmental Microbiology|September 6, 2022
Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age childrenAgnes Delaunay-Moisan, Tiffany Guilleminot, Michaela Semeraro, et al.
Science Translational Medicine|July 26, 2013
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndromeSylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, et al.
Pageof 6